Return to home page
Searching: Muskingum library catalog
We are currently experiencing delivery delays for items requested from other institutions while transitioning to a new statewide delivery service. Please contact your library with questions or advice about alternative resources. Thank you for your patience!
  Previous Record Previous Item Next Item Next Record
  Reviews, Summaries, etc...
Author Herrmann, Mark.
Title Drug and device product liability litigation strategy / Mark Herrmann, David B. Alden.
Imprint Oxford ; New York : Oxford University Press, [2012]

Author Herrmann, Mark.
Subject Products liability -- Medical instruments and apparatus -- United States -- Trial practice.
Products liability -- Drugs -- United States -- Trial practice.
Liability, Legal.
Consumer Product Safety -- legislation & jurisprudence.
Equipment and Supplies.
Legislation, Drug.
United States.
Alt Name Alden, David B.
Description 1 online resource (xi, 524 pages)
Summary "Each year, thousands of lawsuits are filed in federal and state courts seeking recovery from manufacturers of pharmaceuticals and medical devices. These lawsuits include individual actions, actions consolidated into multidistrict litigation, and class actions. The litigation occasionally becomes life-threatening for the defendant corporations, and may breed a public relations nightmare, as occurred with Vioxx, breast implants, and fen-phen. Drug & Device Product Liability Litigation Strategy, by Mark Herrmann and David B. Alden, offers assistance to lawyers who practice in this high-stakes, high-profile, and rapidly-evolving area. The book's primary focus is to provide useful practice pointers and overall strategic guidance for attorneys involved in product liability litigation for prescription drugs and medical devices. It will serve as an indispensable guide to handling such a case from pre-litigation through trial. The legal landscape in this important area is expected to shift as the Supreme Court's decisions in Riegel v. Medtronic, Inc. and Wyeth v. Levine are applied, and as the President and Congress address tort reform and other health care issues. Practitioners will need thoughtful, expert advice to navigate these changes"--Provided by publisher.
Bibliography Note Includes bibliographical references and index.
Contents Introduction -- The FDA's regulation of prescription drugs and devices -- Pre-litigation counseling -- Legal issues & theories -- Consolidated proceedings -- Aggregated proceedings -- Class actions -- Aggregated proceedings -- Multidistrict litigation -- Fact discovery -- Expert retention and discovery -- Expert testimony, Rule 702, And Daubert -- Preemption -- The learned intermediary doctrine -- Motions In limine -- Jury selection -- The trial of a drug or device case.
Note Print version record.
ISBN 9780199750245 (electronic bk.)
0199750246 (electronic bk.)
OCLC # 867050414
Additional Format Print version: Herrmann, Mark. Drug and device product liability litigation strategy 9780199734948 (DLC) 2011024678 (OCoLC)727704983

If you experience difficulty accessing or navigating this content, please contact the OPAL Support Team